| abstract |
Provided are a pharmaceutical composition using UDP-glucose glycoprotein glucose transferase 1 (UGGT1) or a gene encoding the same, a screening method, and the like. Since UGGT1 has an extremely strong proliferative action compared to known pancreatic β-cell growth factor, it itself becomes a useful therapeutic agent for diabetes, and is also useful as a target substance for the development of new therapeutic agents for diabetes. |